305 related articles for article (PubMed ID: 30909401)
1. Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs.
Bayón-Cordero L; Alkorta I; Arana L
Nanomaterials (Basel); 2019 Mar; 9(3):. PubMed ID: 30909401
[TBL] [Abstract][Full Text] [Related]
2. Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems.
Madkhali OA
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268643
[TBL] [Abstract][Full Text] [Related]
3. Solid Lipid Nanoparticles: Applications and Prospects in Cancer Treatment.
Sivadasan D; Ramakrishnan K; Mahendran J; Ranganathan H; Karuppaiah A; Rahman H
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047172
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
5. pH-Responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells.
Chen HH; Huang WC; Chiang WH; Liu TI; Shen MY; Hsu YH; Lin SC; Chiu HC
Int J Nanomedicine; 2015; 10():5035-48. PubMed ID: 26346762
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles, an effective carrier for classical antifungal drugs.
Almawash S
Saudi Pharm J; 2023 Jul; 31(7):1167-1180. PubMed ID: 37273269
[TBL] [Abstract][Full Text] [Related]
7. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
Thukral DK; Dumoga S; Mishra AK
Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
[TBL] [Abstract][Full Text] [Related]
9. Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors.
Mehrdadi S
Adv Pharm Bull; 2023 Jul; 13(3):512-520. PubMed ID: 37646057
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles for sustained pulmonary delivery of Yuxingcao essential oil: Preparation, characterization and in vivo evaluation.
Zhao Y; Chang YX; Hu X; Liu CY; Quan LH; Liao YH
Int J Pharm; 2017 Jan; 516(1-2):364-371. PubMed ID: 27884712
[TBL] [Abstract][Full Text] [Related]
11. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
12. Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery.
Souto EB; Doktorovová S
Methods Enzymol; 2009; 464():105-29. PubMed ID: 19903552
[TBL] [Abstract][Full Text] [Related]
13. Solid lipid nanoparticles for hydrophilic drugs.
Mirchandani Y; Patravale VB; S B
J Control Release; 2021 Jul; 335():457-464. PubMed ID: 34048841
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.
Lin CH; Chen CH; Lin ZC; Fang JY
J Food Drug Anal; 2017 Apr; 25(2):219-234. PubMed ID: 28911663
[TBL] [Abstract][Full Text] [Related]
15. Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.
Xu Y; Zheng Y; Wu L; Zhu X; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(11):9315-9324. PubMed ID: 29484890
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies.
Geszke-Moritz M; Moritz M
Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():982-994. PubMed ID: 27524099
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
Maurya L; Singh S; Rajamanickam VM; Narayan G
Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
[TBL] [Abstract][Full Text] [Related]
18. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles.
Ezzati Nazhad Dolatabadi J; Hamishehkar H; Eskandani M; Valizadeh H
Colloids Surf B Biointerfaces; 2014 May; 117():21-8. PubMed ID: 24607519
[TBL] [Abstract][Full Text] [Related]
20. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status.
Liu M; Wen J; Sharma M
Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
